Moore Kuehn Encourages Investors of TIVO, MEET, QGEN, and GCAP to Contact Law Firm

NEW YORK, March 5, 2020

• TiVo Corporation (NASDAQ: TIVO)

TiVo has signed an agreement to merge with Xperi. Per the agreement, TiVo stockholders will receive 0.455 shares of the new parent company for each share of TiVo common stock owned.  The investigation concerns whether TiVo's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

• The Meet Group, Inc. (Nasdaq: MEET)

Meet had agreed to merge with NuCom Group.   Under the agreement, Meet will be acquired in an all cash transaction for $6.30 per share representing an enterprise value of approximately $500 million. 

• Qiagen (NYSE:QGEN)

Qiagen has agreed to be acquired by Thermo Fisher Scientific.  Under the agreement, Thermo Fisher will acquire all of QIAGEN shares for EUR39 per share. This deal may be unfair to Qiagen shareholders, especially in light of current Qiagen efforts to develop tests for SARS-CoV-2, the virus that causes Covid-19, the virus that causes Covid-19.

• GAIN Capital Holdings (NASDAQ: GCAP)

GAIN Capital has agreed to be acquired by INTL FCStone Inc. Under the agreement GAINS's stockholders will receive $6.00 per share, representing approximately $236 million in equity value.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.